Drug
Vendor:
First CVE: Sep 6, 2024 · Active for 1 year
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
5.4
Avg CVSS
Higher Avg CVSS than 13% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Drug over time
Volume of CVEsAvg CVSS Base Score
First CVE
Sep 6, 2024
22 months ago
Most Recent CVE
Sep 6, 2024
690 days ago
CVE Severity & Scoring
Drug1 CVEs
100%
All CVEs353,173 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None0 (0.0%)
Unknown0 (0.0%)
Required1 (100.0%)
Privileges Required
Low1 (100.0%)
High0 (0.0%)
None0 (0.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2024-44837MEDIUM A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected | Sep 6, 2024 | 5.4 | 17 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Drug
Top CWEs
Versions
| Version | CVE Count | Avg CVSS | Avg EPSS | KEV | Exploits |
|---|---|---|---|---|---|
| 1.0 | 1 | 5.4 | 0.3% | 0 | 0 |